Blockchain for PHARMA Scientists & Engineers
  • What is Blockchain BioPharma?
    • Blockchain BioPharma: R&D Origins
      • Harvard Business Review: Why Big Pharma Is Betting on Blockchain
    • 2022 DEV OPS ROADMAP
    • WEDNESDAY, MARCH 16,2022 SPRINT 0: DEMO VIDEO
    • PHARMA INDUSTRY SOLUTIONS: The 80/20 Non-Profit Pharma Company
    • Our Calling for a Pharmaceutical Coalition
    • BLOCKCHAIN BIOPHARMA: INVESTMENT GOALS AND CRITERIA DATA
    • $20(M-USD) Is The Important Number - As of Now We Have 200 Million ERC & BEP PHARMA Tokens.
    • DAO Mission & Vison
      • Where Will Pharmaceutical eNFT's Come From?
    • Information Architecture Diagram
      • WARNING! ALT-COINS GLOBALLY TARGETED - NEED FOR DEVSECOPS
    • Blockchain BioPharma GAP Analysis
    • Blockchain BioPharma Tokenomics
      • PROPOSED GLOBAL CENTRAL BANK CBDC INTEGRATIONS
      • INTEGRATION POINTS FOR SWIFT & CBDC's
    • BANKING-GRADE SECURITY: SWIFT CODE INTEGRATION
    • Sales & Revenue Model
      • PRODUCT: Quantum SSO
      • PRODUCT: Metaverse Software Apps
      • PRODUCT: eNFT Marketplace for Medicines (Polygon)
        • TYPES OF ENTERPRISE PHARMA eNFT’s:
      • PRODUCT: Metaverse of PHARMA - Introducing CloudLab (VR/AR)
      • SERVICE: Metaverse Development MSP
        • Blockchain BioPharma: MSP Services Rate Card
      • SERVICE: Private-Label IP Monetization (HyperLedger)
      • SERVICE: ENTERPRISE BLOCKCHAIN SMART CONTRACT GAS-FEES
    • What is the Pharmaceutical Token (Ticker: PHARMA)?
      • Are PHARMA Tokens Regulated?
      • Legal Position on the Pharmaceutical Token
      • Using Ethereum Blockchain for Pharmacogenomics Smart Contracts
    • Where Can You Download The Blockchain BioPharma Desktop Applications?
    • What Industries Do We Target?
    • Are PHARMA Tokens on the Cryptocurrency Exchanges?
    • Who Uses The Blockchain BioPharma Application?
    • Does Blockchain BioPharma Loan Money to Drug Developers?
    • Desktop Software Demo
    • Enterprise Pharma eNFT Example
    • Artificial Intelligence & Machine Learning
    • STATE OF THE METAVERSE UNION - Metaverse Market Research
    • Q2 - 2022: Crowdsale
    • Smart Contract Types
    • Competitive Landscape
      • AGILE: Our Competitive Advantage
  • The Competition Justifies our Business Model
    • COMPETITOR #1: Molecule.to
    • COMPETITOR #2: Pharmalyse Finance
  • Get in Touch With Our Community
  • 100% Regulatory and Compliance Transparency
    • Crypto Accounting 101: Price Water House Coopers Regulatory Compliance Opinion
Powered by GitBook
On this page

Was this helpful?

  1. What is Blockchain BioPharma?

Blockchain BioPharma Tokenomics

The term "Tokenomics" refers to the economics of a crypto token, including its utility and governance features.

PreviousBlockchain BioPharma GAP AnalysisNextBANKING-GRADE SECURITY: SWIFT CODE INTEGRATION

Last updated 3 years ago

Was this helpful?

Blockchain BioPharma's ERC-20 Pharmaceutical Token (Ticker: PHARMA) holds the following Desirable Features for investors, DAO Voters, Owners, and Franchisees:

  • Pharmaceutical Token is a Derivative: "Deriving" in our case by the 50% Stake we hold in our entire eNFT or Enterprise Non-Fungible Marketplace for Medicines.

  • Pharmaceutical Token is a Utility Token. A utility token is a crypto token that serves some use case within a specific ecosystem. In the case of Blockchain BioPharma, it grants voting rights on the DAO, which will govern the company's operations. Ultimately, we envision Blockchain BioPharma becoming completely decentralized, with robust smart contracts that fulfill the mission of providing benefits to humanity in pharmaceuticals, nutrition, and life science.

  • Pharmaceutical Token is an #AltCoin. An AltCoin means cryptocurrencies other than Bitcoin and Ethereum.

REQUIRED READING: TOKENOMICS: DYNAMIC ADOPTION AND VALUATION - By Lin William Cogn, Ye Li, and Neng Wang

Post VC Funding, the Blockchain BioPharma DAO Executive Team sees the need to hire professional #Derivative and #Currency Designers with at least 30 Years of Experience Between them in the Legal, Regulatory, Compliance, and Currency Trading Space, Preferably at a Market-making Bank.